Global and China RNAi for Therapeutic Market Research by Company, Type & Application 2013-2025

Publisher Name :
Date: 09-Aug-2019
No. of pages: 71

Summary

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Market Segment as follows:

By Type

- siRNA

- miRNA

- shRNA

By Application

- Cancer

- Cardiovascular

- HBV

- Others

By Company

- Alnylam Pharmaceuticals

- Arrowhead

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Quark Pharmaceuticals

- RXi Pharmaceuticals

- miRagen Therapeutics

- Gradalis

- Sirnaomics

The main contents of the report including:

Section 1: Product definition, type and application, global and China market overview;

Section 2: Global and China Market competition by company;

Section 3: Global and China sales revenue, volume and price by type;

Section 4: Global and China sales revenue, volume and price by application;

Section 5: China export and import;

Section 6: Company information, business overview, sales data and product specifications;

Section 7: Industry chain and raw materials;

Section 8: SWOT and Porter's Five Forces;

Section 9: Conclusion.

Global and China RNAi for Therapeutic Market Research by Company, Type & Application 2013-2025

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 siRNA
1.1.2.2 miRNA
1.1.2.3 shRNA
1.1.3 Market by Application
1.1.3.1 Cancer
1.1.3.2 Cardiovascular
1.1.3.3 HBV
1.1.3.4 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Alnylam Pharmaceuticals
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Arrowhead
6.3 Dicerna Pharmaceuticals
6.4 Mirna Therapeutics
6.5 Quark Pharmaceuticals
6.6 RXi Pharmaceuticals
6.7 miRagen Therapeutics
6.8 Gradalis
6.9 Sirnaomics
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Tables

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table China Market Sales Revenue by Company 2013-2017
Table China Market Sales Revenue Share by Company 2013-2017
Table China Market Sales Volume by Company 2013-2017
Table China Market Sales Volume Share by Company 2013-2017
Table China Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table China Market Sales Revenue by Type 2013-2017
Table China Market Sales Revenue Share by Type 2013-2017
Table China Market Sales Volume by Type 2013-2017
Table China Market Sales Volume Share by Type 2013-2017
Table China Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table China Market Sales Revenue by Application 2013-2017
Table China Market Sales Revenue Share by Application 2013-2017
Table China Market Sales Volume by Application 2013-2017
Table China Market Sales Volume Share by Application 2013-2017
Table China Price by Application 2013-2017
Table China Export 2013-2017 (Million USD)
Table China Export 2013-2017 (Volume)
Table China Import 2013-2017 (Million USD)
Table China Import 2013-2017 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Arrowhead
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Mirna Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Quark Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of RXi Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of miRagen Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Gradalis
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Sirnaomics

List of Figures

Figure siRNA Market Size and CAGR 2013-2018 (Million USD)
Figure siRNA Market Size and CAGR 2013-2018 (Volume)
Figure siRNA Market Forecast and CAGR 2019-2025 (Million USD)
Figure siRNA Market Forecast and CAGR 2019-2025 (Volume)
Figure miRNA Market Size and CAGR 2013-2018 (Million USD)
Figure miRNA Market Size and CAGR 2013-2018 (Volume)
Figure miRNA Market Forecast and CAGR 2019-2025 (Million USD)
Figure miRNA Market Forecast and CAGR 2019-2025 (Volume)
Figure shRNA Market Size and CAGR 2013-2018 (Million USD)
Figure shRNA Market Size and CAGR 2013-2018 (Volume)
Figure shRNA Market Forecast and CAGR 2019-2025 (Million USD)
Figure shRNA Market Forecast and CAGR 2019-2025 (Volume)
Figure Cancer Market Size and CAGR 2013-2018 (Million USD)
Figure Cancer Market Size and CAGR 2013-2018 (Volume)
Figure Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Figure Cancer Market Forecast and CAGR 2019-2025 (Volume)
Figure Cardiovascular Market Size and CAGR 2013-2018 (Million USD)
Figure Cardiovascular Market Size and CAGR 2013-2018 (Volume)
Figure Cardiovascular Market Forecast and CAGR 2019-2025 (Million USD)
Figure Cardiovascular Market Forecast and CAGR 2019-2025 (Volume)
Figure HBV Market Size and CAGR 2013-2018 (Million USD)
Figure HBV Market Size and CAGR 2013-2018 (Volume)
Figure HBV Market Forecast and CAGR 2019-2025 (Million USD)
Figure HBV Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global RNAi for Therapeutic Market Size and CAGR 2013-2017 (Million USD)
Figure Global RNAi for Therapeutic Market Size and CAGR 2013-2017 (Volume)
Figure Global RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Volume)
Figure China RNAi for Therapeutic Market Size and CAGR 2013-2017 (Million USD)
Figure China RNAi for Therapeutic Market Size and CAGR 2013-2017 (Volume)
Figure China RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Million USD)
Figure China RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure RNAi for Therapeutic SWOT List
Figure RNAi for Therapeutic Porter's Five Forces
  • Global RNAi for Therapeutic Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 131
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global Targeted RNA Sequencing Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 18-Nov-2019        Price: US 2900 Onwards        Pages: 184
    The Targeted RNA Sequencing market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Targeted RNA Sequencing. Global Targeted RNA Sequencing industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, mark......
  • Global RNAi for Therapeutic Market Study 2016-2026, by Segment (siRNA, miRNA,) , by Market (Cancer, Cardiovascular,) , by Company (Alnylam Pharmaceuticals, Arrowhead,)
    Published: 17-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024
    Published: 01-Nov-2019        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 2802.7 million by 2024, from US$ 1186.9 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by ......
  • Global RNAi For Therapeutic Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 113
    The RNAi for Therapeutic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the RNAi for Therapeutic industrial chain, this report mainly elaborates the definition, types, applications and major players of RNAi for Therapeutic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ind......
  • Global RNA In Situ Hybridization Market Professional Survey Report 2019
    Published: 17-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global RNA In Situ Hybridization market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on RNA In Situ Hybridization volume and value at global level, regional level and company level. From a global perspective, this report represents overall RNA In Situ Hybridization market size by analyzing historical data and future prospect. Regionally, this report categorizes the production,......
  • Global Antisense and RNAi Therapeutics Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the......
  • NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
    Published: 27-Sep-2019        Price: US 4950 Onwards        Pages: 140
    “The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.” The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA ......
  • Global Rnai Therapeutics Industry Market Research Report
    Published: 26-Sep-2019        Price: US 2960 Onwards        Pages: 122
    The Rnai Therapeutics market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Rnai Therapeutics industrial chain, this report mainly elaborates the definition, types, applications and major players of Rnai Therapeutics market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry dev......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs